These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15097137)

  • 1. Pseudohypopyon following intravitreal triamcinolone acetonide injection.
    Sharma MC; Lai WW; Shapiro MJ
    Cornea; 2004 May; 23(4):398-9. PubMed ID: 15097137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.
    Nelson ML; Tennant MT; Sivalingam A; Regillo CD; Belmont JB; Martidis A
    Retina; 2003 Oct; 23(5):686-91. PubMed ID: 14574256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid hypopyon following intravitreal triamcinolone acetonide injection in a pseudophakic patient.
    Amato JE; Lee DH; Santos BA; Akduman L
    Ocul Immunol Inflamm; 2005; 13(2-3):245-7. PubMed ID: 16019686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohypopyon after intravitreal triamcinolone acetonide injection for cystoid macular edema.
    Moshfeghi AA; Scott IU; Flynn HW; Puliafito CA
    Am J Ophthalmol; 2004 Sep; 138(3):489-92. PubMed ID: 15364241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection.
    Roth DB; Chieh J; Spirn MJ; Green SN; Yarian DL; Chaudhry NA
    Arch Ophthalmol; 2003 Sep; 121(9):1279-82. PubMed ID: 12963610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudohypopyon immediately after intravitreal injection of triamcinolone acetonide--case reports.
    Campos VE; Maia A; Muccioli C; Belfort R
    Arq Bras Oftalmol; 2005; 68(2):251-2. PubMed ID: 15905950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudo-endophthalmitis after intravitreal injection of triamcinolone.
    Sutter FK; Gillies MC
    Br J Ophthalmol; 2003 Aug; 87(8):972-4. PubMed ID: 12881337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.
    Ergun E; Maár N; Ansari-Shahrezaei S; Wimpissinger B; Krepler K; Wedrich A; Stur M
    Am J Ophthalmol; 2006 Jul; 142(1):10-16. PubMed ID: 16815246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
    Yoon SJ; Rhee DY; Marx JL; Blaha GR; Rogers AH; Baumal CR; Reichel E; Duker JS
    Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute endophthalmitis incidence: intravitreal triamcinolone.
    Westfall AC; Osborn A; Kuhl D; Benz MS; Mieler WF; Holz ER
    Arch Ophthalmol; 2005 Aug; 123(8):1075-7. PubMed ID: 16087840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ptosis following an intravitreal injection of triamcinolone acetonide.
    Viola F; Morescalchi F; Ratiglia R; Staurenghi G
    Eye (Lond); 2007 Mar; 21(3):421-3. PubMed ID: 16498434
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninfectious hypopion after intravitreal triamcinolone acetonide injection for central retinal vein occlusion: a case report.
    Chiu YT; Tsai YY; Lin JM
    Kaohsiung J Med Sci; 2005 Oct; 21(10):466-9. PubMed ID: 16302450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute retinal necrosis post intravitreal injection of triamcinolone acetonide.
    Toh T; Borthwick JH
    Clin Exp Ophthalmol; 2006; 34(4):380-2. PubMed ID: 16764663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.
    Augustin AJ; Schmidt-Erfurth U
    Ophthalmology; 2006 Jan; 113(1):14-22. PubMed ID: 16360209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.
    Lee J; Freeman WR; Azen SP; Chung EJ; Koh HJ
    Retina; 2007; 27(9):1205-13. PubMed ID: 18046226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unusual clinical features and histopathological findings in a case of Pseudo-endophthalmitis in neovascular glaucoma.
    Oli A; Bhatia A
    Rom J Ophthalmol; 2024; 68(2):182-186. PubMed ID: 39006339
    [No Abstract]   [Full Text] [Related]  

  • 19. Complications of intravitreal injection of triamcinolone acetonide.
    Ozkiriş A; Erkiliç K
    Can J Ophthalmol; 2005 Feb; 40(1):63-8. PubMed ID: 15825532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006.
    Stepien KE; Eaton AM; Jaffe GJ; Davis JL; Raja J; Feuer W
    Retina; 2009 Feb; 29(2):207-13. PubMed ID: 19050670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.